Do primary health care nurses address cardiovascular risk in diabetes patients?

Diabetes Research and Clinical Practice

Volumn 106, Issue 2, 2014, Pages 212-220

  Daly, Barbara ^a   Kenealy, Timothy ^b   Arroll, Bruce ^b   Sheridan, Nicolette ^a   Scragg, Robert ^b  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Blood pressure; Diabetes; Prevention; Primary health care nurses; Smoking

Indexed keywords

CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHILD; CHOLESTEROL BLOOD LEVEL; CONSULTATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; NURSE; NURSING CARE; NURSING KNOWLEDGE; PHYSICAL ACTIVITY; PRIMARY HEALTH CARE; RISK ASSESSMENT; SMOKING; CARDIOVASCULAR DISEASES; INCIDENCE; MIDDLE AGED; NEW ZEALAND; NURSING; NURSING PRACTICE; PATIENT REFERRAL; PROCEDURES; QUESTIONNAIRE; RISK FACTOR; RISK MANAGEMENT; STANDARDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW ZEALAND; NURSE'S PRACTICE PATTERNS; NURSES; PRIMARY HEALTH CARE; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK FACTORS; RISK MANAGEMENT; YOUNG ADULT;

EID: 84920652110     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.08.031     Document Type: Article

References (50)

1. Ministry of Health Diabetes Surveillance 2007, Ministry of Health, Wellington (New Zealand).
2. Doshi K.B., Kashyap S.R., Brennan D.M., Hoar B.M., Cho L., Hoogwerf B.J. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study. Diabetes Obes Metab 2009, 11:102-108.
3. New Zealand Guidelines Group New Zealand primary care handbook 2012, New Zealand Guidelines Group & Ministry of Health, Wellington (New Zealand). 3rd ed.
4. Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Halsey J., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370:1829-1839.
5. Fagard R.H. Smoking amplifies cardiovascular risk in patients with hypertension and diabetes. Diabetes Care 2009, 32:S429-S431.
6. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004, 328:1519.
7. Peto R., Lopez A.D., Boreham J., Thun M., Heath C.J. Mortality from smoking in developed countries 1950-2000: indirect estimates from national vital statistics 1994, Oxford University Press, (2004 update on www.ctsu.ox.ac.uk).
8. Brown W.V. Risk factors for vascular disease in patients with diabetes. Diab Obesity Metab 2000, 2(Suppl 2):S11-S18.
9. Ito H., Antoku S., Furusho M., Shinozaki M., Abe M., Mifune M., et al. The prevalence of the risk factors for atherosclerosis among type 2 diabetic patients is greater in the progressive stages of chronic kidney disease. Nephron Extra 2013, 3:66-72.
10. Chakkarwar V.A. Smoking in diabetic nephropathy: sparks in the fuel tank. World J Diabetes 2012, 3:186-195.
11. Marso S.P., Hiatt W.R. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 2006, 47:921-929.
12. American Diabetes Association Standards of medical care in diabetes-2012. Diabetes Care 2012, 35(Suppl 1):S11-S63.
13. Khan N.A., Hemmelgarn B., Herman R.J., Bell C.M., Mahon J.L., Leiter L.A., et al. The 2009 canadian hypertension education program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol 2009, 25:287-298.
14. Dobarro D., Gomez-Rubin M.C., Sanchez-Recalde A., Moreno R., Galeote G., Jimenez-Valero S., et al. Current pharmacological approach to restore endothelial dysfunction. Cardiovasc Hematol Agents Med Chem 2009, 7:212-222.
15. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38): UK prospective diabetes study (UKPDS) group. BMJ 1998, 317:703-713.
16. Conen D. Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens 2008, 26:1290-1299.
17. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145-153.
18. Arguedas J.A., Leiva V., Wright J.M. Blood pressure targets for hypertension in people with diabetes mellitus. Cochrane Database Syst Rev 2013, 10:CD008277.
19. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006, 47:C7-C12.
20. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278.
21. Health Quality Ontario Specialized nursing practice for chronic disease management in the primary care setting: an evidence-based analysis. Ont Health Technol Assess Ser 2013, 13:1-66.
22. Ministry of Health The primary health care strategy 2001, Ministry of Health, Wellington (New Zealand).
23. Daly B., Arroll B., Sheridan N., Kenealy T., Scragg R. Characteristics of nurses providing diabetes community and outpatient care in Auckland. J Prim Health Care 2013, 5:19-27.
24. Ministry of Health. Investing in health: Whakatohutia Te Oranga Tangata: a framework for activating primary health care nursing in New Zealand 2003 [cited 13.03.13] Available from:. http://www.moh.govt.nz/notebook/nbbooks.nsf/0/3595173DEE935F45CC25713D006EFB30/$file/InvestingInHealth.pdf.
25. Ministry of Health Implementing the New Zealand health strategy 2012, Ministry of Health, Wellington (New Zealand).
26. Daly B., Arroll B., Sheridan N., Kenealy T., Scragg R. Diabetes knowledge of nurses providing community care for diabetes patients in Auckland, New Zealand. Prim Care Diabetes 2014, 8:215-223.
27. Robinson T., Simmons D., Scott D., Howard E., Pickering K., Cutfield R., et al. Ethnic differences in type 2 diabetes care and outcomes in Auckland: a multiethnic community in New Zealand. N Z Med J 2006, 119:U1997.
28. Chew B.H., Shariff-Ghazali S., Lee P.Y., Cheong A.T., Mastura I., Haniff J., et al. Type 2 diabetes mellitus patient profiles, diseases control and complications at four public health facilities - a cross-sectional study based on the Adult Diabetes Control and Management (ADCM) Registry 2009. Med J Malaysia 2013, 68:397-404.
29. Fu A.Z., Zhang Q., Davies M.J., Pentakota S.R., Radican L., Seck T. Underutilization of statins in patients with type 2 diabetes in US clinical practice: a retrospective cohort study. Curr Med Res Opin 2011, 27:1035-1040.
30. Braga M., Casanova A., Teoh H., Dawson K.C., Gerstein H.C., Fitchett D.H., et al. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol 2010, 26:297-302.
31. Ministry of Health The Health of New Zealand Adults 2011/12: key findings of the New Zealand health survey 2012, Ministry of Health, Wellington (New Zealand).
32. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
33. Patel A., MacMahon S. Chalmers J. intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572.
34. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
35. Stead L.F., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008, CD000146.
36. Ministry of Health Primary care health targets - 2012/13 quarter one - results summary of primary health organisation performance against the health targets for the first quarter 2012/13 2013, Ministry of Health, Wellington (New Zealand).
37. Borland R., Li L., Driezen P., Wilson N., Hammond D., Thompson M.E., et al. Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys. Addiction 2012, 107:197-205.
38. Thornley S., Jackson G., McRobbie H., Sinclair S., Smith J. Few smokers in South Auckland access subsidised nicotine replacement therapy. N Z Med J 2010, 123:16-27.
39. Cox L.S., Cupertino A.P., Mussulman L.M., Nazir N., Greiner K.A., Mahnken J.D., et al. Design and baseline characteristics from the KAN-QUIT disease management intervention for rural smokers in primary care. Prev Med 2008, 47:200-205.
40. Eakin E., Reeves M., Lawler S., Graves N., Oldenburg B., Del Mar C., et al. Telephone counseling for physical activity and diet in primary care patients. Am J Prev Med 2009, 36:142-149.
41. Lawler S.P., Winkler E., Reeves M.M., Owen N., Graves N., Eakin E.G. Multiple health behavior changes and co-variation in a telephone counseling trial. Ann Behav Med 2010, 39:250-257.
42. Sacco W.P., Malone J.I., Morrison A.D., Friedman A., Wells K. Effect of a brief, regular telephone intervention by paraprofessionals for type 2 diabetes. J Behav Med 2009, 32:349-359.
43. Hemmingsen B., Lund S.S., Gluud C., Vaag A., Almdal T., Hemmingsen C., et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 2011, 343:d6898.
44. UK Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK prospective diabetes study (UKPDS) group. Lancet 1998, 352:854-865.
45. Daly B, Arroll B, Kenealy T, Sheridan N, Scragg R. Management of diabetes by primary health care nurses in Auckland, New Zealand, J Prim Health Care [in press].
46. Miller W.C., Koceja D.M., Hamilton E.J. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. Int J Obes Relat Metab Disord 1997, 21:941-947.
47. Whelton S.P., Chin A., Xin X., He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002, 136:493-503.
48. Goolsby M.J. 2006 American academy of nurse practitioners diabetes management survey. J Am Acad Nurse Pract 2007, 19:496-498.
49. Bannink L., Wells S., Broad J., Riddell T., Jackson R. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1). N Z Med J 2006, 119:U2313.
50. Wells S., Furness S., Rafter N., Horn E., Whittaker R., Stewart A., et al. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice. Eur J Cardiovasc Prev Rehabil 2008, 15:173-178.